4Bornstein E,Lenchner E,Donnenfeld A,et al.Advanced maternal age as a sole indication for genetic amniocentesis;risk-benefit analysis based on a large database reflecting the current common practice. Journal of Perinatal Medicine . 2009
5Karaoguz MY,Bal F,Yakut T,et al.Cytogenetic results of amniocentesis materials:incidence of abnormal karyotypes in the Turkish collaborative study. Genetic Counseling . 2006
6Avtjitei MC,Moscalu M,Martiniuc V,et al.Performance of different methods of estimating risk screening for chromosomal anomalies. Rev Med ChirSoc Med Nat Iasi . 2012
7Bornslein E, Lenchner E, Donnenfeld A, et al.Advanced maternal age as a sole indication for genetic amniocentesis Frisk-benefit analysis based on a large database reflecting the current commonpractice[J].J Perinal Med, 2009, 37 (2) :99-102.
8Karaoguz M Y, et al. Cytogenetic results of amniocentesis materials incidence of abnormal karyotypes in the Turkish collaborative Study[J].Gebet Couns, 2006, 17 (2) :219-230.
9Ekin A, Gezer CE, Taner M, et al. Cytogenetic analysis of 6 142 amniocentesis cases: a 6-year single centre experience[J]. J Obstet Gynaecol,2014,34(8) 571-575.
